Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-02-03 @ 5:01 PM
Study NCT ID:
NCT00018018
Status:
COMPLETED
Last Update Posted:
2019-12-12
First Post:
2001-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency
Sponsor:
National Human Genome Research Institute (NHGRI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Severe Combined Immunodeficiency Syndrome | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Gene Therapy | View |
| None | ADA-SCID | View |
| None | Stem Cells | View |
| None | Retroviruses | View |
| None | Immune Deficiency Disease | View |
| None | Adenosine Deaminase Deficiency | View |
| None | ADA-Deficiency | View |
| None | Retroviral Vectors | View |
| None | Hematopoietic Progenitors | View |
| None | Severe Combined Immunodeficiency | View |
| None | SCID | View |
| None | Immune Deficiency | View |